[Elevated substance P content in sputum and plasma in patients with COPD and its relationship with FEV1/FVC].
To investigate the role of substance P(SP) of the nonadrenergic system within airways in the pathogenesis of COPD, and analyze the relationship between level of SP and FEV1/FVC in COPD patients. SP concentration in sputum and plasma in 20 patients with COPD and 20 normal volunteers was examined and was measured by radioimmunoassay. The sputum SP concentration was significantly higher in patients with COPD (57.3 +/- 14.5) pmol/L than that in normal volunteers(5.9 +/- 2.6) pmol/L, P < 0.01, the plasma SP concentration was significantly higher in COPD patients (8.6 +/- 3.9) pmol/L than that in normal volunteers (3.8 +/- 2.0) pmol/L, P < 0.05. The plasma and sputum SP concentration correlated with FEV1/FVC in COPD patients (r = -0.591, r = -0.642, P < 0.05). These data suggest that neurogenic inflammation may be involved in the airway inflammation process and subsequent airway narrowing in COPD.